Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands
- PMID: 20598845
- DOI: 10.1016/j.ejso.2010.06.020
Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands
Abstract
Background: Care processes for patients with NSCLC can vary by provider, which may lead to unwanted variation in outcomes. Therefore, in modern health care an increased focus on guideline development and implementation is seen. It is expected that more guideline adherence leads to a higher number of patients receiving optimal treatment for their cancer which could improve overall survival.
Objective: The aim of this study was to evaluate variations in treatment patterns and outcomes of patients with NSCLC treated in different (types of) hospitals and regions in the Netherlands. Especially, variation in the percentage of patients receiving the optimal treatment for the stage of their disease, according to the Dutch national guideline of 2004, was analyzed.
Methods: All patients with a histological confirmed primary NSCLC diagnosed in the period 2001-2006 in all Dutch hospitals (N = 97) were selected from the population-based Netherlands Cancer Registry. Hospitals were divided in groups based on their region (N = 9), annual volume of NSCLC patients, teaching status and presence of radiotherapy facilities. Stage-specific differences in optimal treatment rates between (groups of) hospitals and regions were evaluated.
Results: In the study period 43 544 patients were diagnosed with NSCLC. The resection rates for stage I/II NSCLC patients increased during the study period, but resection rates varied by region and were higher in teaching hospitals for thoracic surgeons (OR 1.5; 95%CI 1.2-1.9, p = 0.001) and in hospitals with a diagnostic volume of more than 50/year (OR 1.3; 95%CI 1.1-1.5, p = 0.001). Also the use of chemoradiation in stage III patients increased, though marked differences between hospitals in the use of chemoradiation for stage III patients were revealed. Differences in optimal treatment rates between hospitals led to differences in survival.
Conclusion: Treatment patterns and outcome of NSCLC patients in the Netherlands varied by region and the hospital their cancer was diagnosed in. Though resection rates were higher in hospitals training thoracic surgeons, variation between individual hospitals was much more distinct. Hospital characteristics like a high diagnostic volume, teaching status or availability of radiotherapy facilities proved no guarantee for optimal treatment rates.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S74-82. doi: 10.1016/j.ejso.2010.06.028. Epub 2010 Jul 3. Eur J Surg Oncol. 2010. PMID: 20598844
-
The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer.Lung Cancer. 2008 Jun;60(3):441-51. doi: 10.1016/j.lungcan.2007.10.029. Epub 2007 Dec 27. Lung Cancer. 2008. PMID: 18164099
-
Disparities in quality of care for colon cancer between hospitals in the Netherlands.Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S64-73. doi: 10.1016/j.ejso.2010.05.026. Eur J Surg Oncol. 2010. PMID: 20599339
-
Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Arch Phys Med Rehabil. 2008. PMID: 18373987 Review.
-
A cross-country review of data collected on non-small cell lung cancer (NSCLC) patients in cancer registries, databases, retrospective and non-randomized prospective studies.J Med Econ. 2013;16(1):134-49. doi: 10.3111/13696998.2012.703631. Epub 2012 Jul 5. J Med Econ. 2013. PMID: 22702446 Review.
Cited by
-
Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base.J Am Coll Surg. 2015 Aug;221(2):550-63. doi: 10.1016/j.jamcollsurg.2015.03.056. Epub 2015 Apr 16. J Am Coll Surg. 2015. PMID: 26206651 Free PMC article.
-
Canadian brain cancer survival rates by tumour type and region: 1992-2008.Can J Public Health. 2016 Jun 27;107(1):e37-e42. doi: 10.17269/cjph.107.5209. Can J Public Health. 2016. PMID: 27348108 Free PMC article.
-
'Care for Outcomes': systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer.BMJ Open. 2021 Jan 15;11(1):e043229. doi: 10.1136/bmjopen-2020-043229. BMJ Open. 2021. PMID: 33452199 Free PMC article.
-
Reflections on the 14th World Conference on Lung Cancer: A European Perspective.Oncologist. 2012 Mar;17(3):463-465. doi: 10.1634/theoncologist.2011-0309. Epub 2012 Feb 21. Oncologist. 2012. PMID: 22357729 Free PMC article.
-
Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens?Ann Surg Oncol. 2015 Oct;22(11):3582-9. doi: 10.1245/s10434-015-4385-7. Epub 2015 Feb 18. Ann Surg Oncol. 2015. PMID: 25691277 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical